Unsubstanciated, meaningless crap.
If this is not misleading the market i don't know what is.
1/ Open label, single centre trials are totally meaningless in getting a new drug approved.
In fact, they are regarded in the scientific world as being set up solely for the purpose of boosting penny-dreadful biotech stocks - and as such are actually a huge red flag to regulators and serious investors
( there are some very narrow exceptions - ie, they are sometimes legitimately used and accepted for expanding the conditions that an already approved drug can be used for)
They are NEVER employed for getting a new drug approved as they have none of the scientific rigor needed for this - let alone for powerful new psycodelics.
2/ Non peer reviewed reports written and released by the company of 5 patients results is an absolute joke.
Willian Ley should hang his head in shame for his statements about the value of these trials - and for these pathetic and scientifically meaningless "results" he just signed off on and released.
Don't get sucked in by these Disallowed salesmen's BS scientific jargon and spin. It is a con.
I give you my word of honour - Halucinex is a dog.
PS, By the way, lol..
Whatever happened to the much touted, no committment, open ended, open priced deal to off-load Halucinex to another failing, deap-in-debt, penny dreadful in the USA - in that very vaguely worded and highly suss deal put together by VIT BOD's close mate and parasite of choice >> ie, Everblue?
Just more - like these trial results - meaningless and misleading Scotch mist?
- Forums
- ASX - By Stock
- ME1
- Ann: Halucenex Phase II Clinical Trial Update
Ann: Halucenex Phase II Clinical Trial Update, page-15
-
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ME1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.125M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
ME1 (ASX) Chart |
Day chart unavailable